Optimizing Psoriasis Treatment of Etanercept Combined Methotrexate
Status:
Completed
Trial end date:
2018-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate whether etanercept combined with methotrexate are
superiority than etanercept as monotherapy in the treatment of chinese severe plaque
psoriasis. A phase IV, multicenter, randomized, double-blind, controlled trial was
conducted.The primary outcome was Change from baseline in plaque psoriasis as assessed by
PASI (psoriasis area and severity index) response or PASI75 (a patient that has an
improvement from baseline PASI of at least 75%)